GH Research Stock (NASDAQ: GHRS) stock price, news, charts, stock research, profile.
Open | $12.00 |
Close | - |
Volume / Avg. | 2.12K / 69.65K |
Day Range | 11.74 - 12.02 |
52 Wk Range | 5.05 - 14.99 |
Market Cap | $610.81M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 8.94% |
Days to Cover | 17.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GH Research (NASDAQ:GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Xeris Biopharma Holdings (NASDAQ:XERS).
There is no analysis for GH Research.
GH Research has a consensus price target of $33.57.
The stock price for GH Research (NASDAQ: GHRS) is $11.99 last updated June 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for GH Research.
GH Research’s Q2 earnings are confirmed for Wednesday, August 21, 2024.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.